GT BIOPHARMA INC (GTBP) Stock Cash Flow
USA - NASDAQ:GTBP - US36254L3087 - Common Stock
0.6555 USD
-0.03 (-4.63%)
0.6705 USD
+0.02 (+2.29%)
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -11.67M | -13.16M | -7.60M | -20.88M | -58.01M | |||
| Depreciation Amortization | undefined | null | null | null | null | |||
| Income Taxes - Deferred | undefined | null | null | null | null | |||
| Accounts Payable And Accrued Liabilities | undefined | undefined | undefined | undefined | undefined | |||
| Change In Working Capital | 841.00K | 775.00K | 1.82M | -1.99M | 7.25M | |||
| Interest Paid | 0 | 0 | 213.00K | 0 | 0 | |||
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | |||
| Other non cash items | -112.00K | -517.00K | -3.08M | 7.66M | 35.16M | |||
| OPERATING CASH FLOW | -10.94M | -12.90M | -8.85M | -15.22M | -15.61M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | undefined | null | null | null | null | |||
| Other Investing Activity | 7.86M | 12.89M | -2.01M | 12.14M | -23.04M | |||
| INVESTING CASH FLOW | 7.86M | 12.89M | -2.01M | 12.14M | -23.04M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | undefined | null | null | 0 | 1.21M | |||
| Stock Issued/Repurchased | 3.59M | 2.98M | 6.27M | 0 | 41.11M | |||
| Dividend Paid | undefined | null | null | null | null | |||
| Other Financing Activity | undefined | null | null | -224.00K | null | |||
| FINANCING CASH FLOW | 3.59M | 2.98M | 6.27M | -224.00K | 42.32M | |||
| Exchange Rate Effect | undefined | null | null | null | null | |||
| CHANGE IN CASH | 508.00K | 2.96M | -4.59M | -3.30M | 3.67M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -10.94M | -12.90M | -8.85M | -15.22M | -15.61M | |||
| Capital Expenditure | undefined | null | null | null | null | |||
| FREE CASH FLOW | -10.94M | -12.90M | -8.85M | -15.22M | -15.61M | |||
All data in USD